MapLight Therapeutics, Inc. (MPLT) financial statements and ratios from SEC XBRL: revenue $5.52M (TTM), net margin -2920.5%, revenue growth 22.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $5.52M |
| Net Margin | -2920.5% |
| Revenue Growth (YoY) | 22.5% |
| EPS Growth (YoY) | -82.4% |
| FCF Growth (YoY) | 74.2% |
| Price / Book | 1.50 |
| Price / Sales | 59.25 |
| FCF Yield | -55.3% |
| Altman Z-Score | 12.45 (safe) |
| Sector P/E (Healthcare) | 21.7 |
MPLT overview · MPLT earnings · MPLT KPIs · MPLT investor relations · MPLT ownership · MPLT peers · MPLT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.